Qube Research & Technologies (QRT)
HZNP

Qube Research & Technologies (QRT)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-727,409
Closed -$84.2M – 4943
2023
Q3 		$84.2M Buy
727,409
+157,987
+28% +$17M 0.22% 109
2023
Q2 		$58.6M Sell
569,422
-96,363
-14% -$10.2M 0.21% 125
2023
Q1 		$72.7M Buy
+665,785
New +$73.6M 0.31% 45
2022
Q4 		– Sell
-266,931
Closed -$16.5M – 3227
2022
Q3 		$16.5M Sell
266,931
-374,095
-58% -$26.1M 0.1% 283
2022
Q2 		$51.1M Buy
641,026
+293,952
+85% +$27.8M 0.38% 46
2022
Q1 		$36.5M Buy
347,074
+85,232
+33% +$8.31M 0.31% 60
2021
Q4 		$28.2M Buy
+261,842
New +$28.6M 0.22% 91
2021
Q2 		– Sell
-18,045
Closed -$1.66M – 3042
2021
Q1 		$1.66M Buy
+18,045
New +$1.52M 0.03% 677
2020
Q4 		– Sell
-117,952
Closed -$9.16M – 2373
2020
Q3 		$9.16M Buy
117,952
+94,062
+394% +$6.47M 0.13% 191
2020
Q2 		$1.33M Buy
+23,890
New +$1.02M 0.02% 777

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Qube Research & Technologies (QRT)'s HZNP Position: Q4 2023 in Review

Qube Research & Technologies (QRT) sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 727,409 shares — an estimated $84.2M sold.

Qube Research & Technologies (QRT) first reported a position in HZNP in Q2 2020 and held it in 10 quarters. The position peaked at $84.2M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Qube Research & Technologies (QRT) reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 727,409 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $84.2M.
  • Qube Research & Technologies (QRT) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 10 quarters.
  • Qube Research & Technologies (QRT)'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $84.2M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.